Novo Nordisk A/S
GLP-1/glucagon receptor co-agonists for medical use
Last updated:
Abstract:
The present invention relates to novel glucagon derivatives which are GLP-1/glucagon receptor co-agonists, and to the use of the glucagon derivatives in medicine, such as in the treatment of diabetes, obesity and related diseases and conditions.
Status:
Grant
Type:
Utility
Filling date:
3 Jun 2015
Issue date:
25 Feb 2020